{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-159935","form_type":"8-K","ticker":"VERA","cik":"0001831828","company_name":"Vera Therapeutics, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.541323+00:00","generated_at":"2026-06-01T04:54:17.570959+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Vera Therapeutics appoints Christy Oliger to board; grants 25K share options","bullets":["Christy Oliger appointed as Class III Director effective June 7, 2024, term through 2027 annual meeting.","Received nonstatutory stock option for 25,000 shares vesting monthly over three years.","Annual cash retainer of $40,000 for board service plus $4,000 for Nominating Committee, prorated for 2024.","Awarded 2,987 restricted stock units, fully vested for prior consulting services, settling in 2025.","Will serve on Nominating and Corporate Governance Committee."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-159935","json":"https://secwatch.observer/filing/0001193125-24-159935.json","markdown":"https://secwatch.observer/filing/0001193125-24-159935.md","text":"https://secwatch.observer/filing/0001193125-24-159935.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/d843919d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:54:17.570959+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aae6323f53","claim":"Christy Oliger was appointed as Director at Vera Therapeutics, Inc..","evidence_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","confidence":1.0}],"comparable_filings":[{"accession":"0001206774-26-000308","ticker":"SFST","company_name":"SOUTHERN FIRST BANCSHARES INC","filed_at":"2026-06-02T18:04:40+00:00","headline":"Southern First Bancshares appoints Bryan Kennedy to board; retired banker with 43 years experience","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001206774-26-000308","json":"https://secwatch.observer/filing/0001206774-26-000308.json","markdown":"https://secwatch.observer/filing/0001206774-26-000308.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1090009/000120677426000308/0001206774-26-000308-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1090009/000120677426000308/sfst4646481-8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","comparable_excerpt":"Effective June 1, 2026, the Boards of Directors of Southern First Bancshares, Inc. (the “Company”) and Southern First Bank (the “Bank”) approved the appointment of Mr. Bryan Kennedy as a director.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1090009/000120677426000308/0001206774-26-000308-index.htm"}},{"accession":"0001193125-26-252616","ticker":"GOOD","company_name":"GLADSTONE COMMERCIAL CORP","filed_at":"2026-06-02T12:45:17+00:00","headline":"Gladstone Commercial elects George Stelljes as director; board expands to eight","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252616","json":"https://secwatch.observer/filing/0001193125-26-252616.json","markdown":"https://secwatch.observer/filing/0001193125-26-252616.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1234006/000119312526252616/0001193125-26-252616-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1234006/000119312526252616/d44825d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","comparable_excerpt":"On June 1, 2026, the Board of Directors (the “Board”) of Gladstone Commercial Corporation (the “Company”) elected George “Chip” Stelljes, III to the Board, effective June 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1234006/000119312526252616/0001193125-26-252616-index.htm"}},{"accession":"0001193125-26-252618","ticker":"GAIN","company_name":"GLADSTONE INVESTMENT CORPORATION\\DE","filed_at":"2026-06-02T12:45:17+00:00","headline":"Gladstone Investment Elects George Stelljes to Board, Expands to 8 Directors","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252618","json":"https://secwatch.observer/filing/0001193125-26-252618.json","markdown":"https://secwatch.observer/filing/0001193125-26-252618.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321741/000119312526252618/0001193125-26-252618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321741/000119312526252618/d40927d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","comparable_excerpt":"On June 1, 2026, the Board of Directors (the “Board”) of Gladstone Investment Corporation (the “Company”) elected George “Chip” Stelljes, III to the Board, effective June 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1321741/000119312526252618/0001193125-26-252618-index.htm"}},{"accession":"0001193125-26-252617","ticker":"GLAD","company_name":"GLADSTONE CAPITAL CORP","filed_at":"2026-06-02T12:45:07+00:00","headline":"Gladstone Capital elects George 'Chip' Stelljes as independent director, board expands to eight","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252617","json":"https://secwatch.observer/filing/0001193125-26-252617.json","markdown":"https://secwatch.observer/filing/0001193125-26-252617.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1143513/000119312526252617/0001193125-26-252617-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1143513/000119312526252617/d21227d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","comparable_excerpt":"elected George \"Chip\" Stelljes, III to the Board, effective June 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1143513/000119312526252617/0001193125-26-252617-index.htm"}},{"accession":"0001193125-26-252556","ticker":null,"company_name":"OLD DOMINION ELECTRIC COOPERATIVE","filed_at":"2026-06-02T12:06:21+00:00","headline":"Director Belvin Williamson Jr. resigns from Old Dominion Electric Cooperative board, effective July 28, 2026","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252556","json":"https://secwatch.observer/filing/0001193125-26-252556.json","markdown":"https://secwatch.observer/filing/0001193125-26-252556.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/885568/000119312526252556/0001193125-26-252556-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885568/000119312526252556/ck0000885568-20260528.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","comparable_excerpt":"On May 28, 2026, Belvin Williamson, Jr. notified us that he will resign from the board of directors of Old Dominion Electric Cooperative, effective as of July 28, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/885568/000119312526252556/0001193125-26-252556-index.htm"}},{"accession":"0001104659-26-069164","ticker":"PAGP","company_name":"PLAINS GP HOLDINGS LP","filed_at":"2026-06-02T10:05:30+00:00","headline":"Plains GP Holdings announces CAO succession: Montgomery promoted, Herbold retiring","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069164","json":"https://secwatch.observer/filing/0001104659-26-069164.json","markdown":"https://secwatch.observer/filing/0001104659-26-069164.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581990/000110465926069164/0001104659-26-069164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581990/000110465926069164/tm2614304d4_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","comparable_excerpt":"effective September 1, 2026, Russ Montgomery will be promoted to the position of Vice President, Accounting and Chief Accounting Officer of Plains All American GP LLC, the general partner of PAA, and PAA GP Holdings LLC, the general partner of PAGP.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1581990/000110465926069164/0001104659-26-069164-index.htm"}},{"accession":"0001104659-26-069156","ticker":"PAA","company_name":"PLAINS ALL AMERICAN PIPELINE LP","filed_at":"2026-06-02T10:03:41+00:00","headline":"Plains All American announces CAO retirement and Montgomery promotion effective Sep 1, 2026","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069156","json":"https://secwatch.observer/filing/0001104659-26-069156.json","markdown":"https://secwatch.observer/filing/0001104659-26-069156.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070423/000110465926069156/0001104659-26-069156-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070423/000110465926069156/tm2615397d2_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","comparable_excerpt":"Chris Herbold, who previously served as Senior Vice President, Finance and Chief Accounting Officer of PAA and PAGP, is retiring from the company on August 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1070423/000110465926069156/0001104659-26-069156-index.htm"}},{"accession":"0001104659-26-069119","ticker":"AHCO","company_name":"AdaptHealth Corp.","filed_at":"2026-06-02T01:02:57+00:00","headline":"AdaptHealth amends 8-K to disclose COO Daniel McFadden's compensation: base salary raised to $550K, plus RSU grant","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069119","json":"https://secwatch.observer/filing/0001104659-26-069119.json","markdown":"https://secwatch.observer/filing/0001104659-26-069119.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725255/000110465926069119/0001104659-26-069119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725255/000110465926069119/tm2616604d1_8ka.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On June 7, 2024, the board of directors (the “Board”) of Vera Therapeutics, Inc. (the “Company”) appointed Christy Oliger to the Board, effective immediately.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm","comparable_excerpt":"the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1725255/000110465926069119/0001104659-26-069119-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}